Sirtuins (SIRTs) As a Novel Target in Gastric Cancer.

Int J Mol Sci

Department of Physiology in Health Sciences, Faculty of Health Sciences, Pomeranian Medical University, Szczecin, Żołnierska 54, 70-210 Szczecin, Poland.

Published: December 2022

Gastric cancer is a major health burden worldwide. Among all neoplasms, gastric cancer is the fifth most common and the third most deadly type of cancer. It is known that sirtuins (SIRTs), are NAD-dependent histone deacetylases regulating important metabolic pathways. High expression of SIRTs in the human body can regulate metabolic processes; they prevent inflammation but also resist cell death and aging processes. The seven members of this family enzymes can also play a fundamental role in process of carcinogenesis by influencing cell viability, apoptosis and metastasis. This review collects and discusses the role of all seven sirtuins (SIRT1-SIRT7) in the pathogenesis of gastric cancer (GC).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737976PMC
http://dx.doi.org/10.3390/ijms232315119DOI Listing

Publication Analysis

Top Keywords

gastric cancer
16
sirtuins sirts
8
cancer
5
sirts novel
4
novel target
4
gastric
4
target gastric
4
cancer gastric
4
cancer major
4
major health
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!